Company intelligence / Profile preview

the Environment

Ownership: Private
Development stage: Other

Overview

The Environment is a biotechnology company focused on developing therapies that target the intersection of environmental factors and human biology. The company utilizes a proprietary platform to identify how external environmental triggers influence disease pathways, particularly in the context of inflammation and immunology. By understanding these interactions, The Environment aims to create precision medicines that address the root causes of chronic diseases. The company is currently in the pre-clinical stage, building a pipeline of candidates designed to modulate the body's response to environmental stressors.

Therapeutic areas: Immunology
Modalities: Small moleculeBiologic
Industry: Biotech

Beyond the preview

Go deeper on the Environment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on the Environment.

Explore the full profile